Observational study / 2020
Urinary methylmalonic acid/creatinine ratio was not influenced by renal function and showed diagnostic utility for vitamin B12 deficiency.
Researchers prospectively studied 127 patients with plasma vitamin B12 levels between 201 and 350 ng/L to evaluate the diagnostic utility of the urinary methylmalonic acid/creatinine ratio (uMMA/C) and assess the impact of renal impairment. Unlike plasma homocysteine and plasma MMA, uMMA/C was not dependent on renal function (p = 0.34). uMMA/C achieved an AUC of 0.71 (95% CI: 0.62-0.80), and a threshold of 1.45 umol/mmol provided a specificity of 87.9% (95% CI: 72.0-98.9) for identifying B12 deficiency.
Shows an association, not proof of cause and effect.
- Study type
- Prospective diagnostic study
- Who was studied
- 127 patients with plasma vitamin B12 between 201 and 350 ng/L
- What was measured
- Diagnostic performance of uMMA/C and the effect of renal impairment on uMMA/C
THE PAPER
Diagnostic Performances of Urinary Methylmalonic Acid/Creatinine Ratio in Vitamin B12 Deficiency.
Supakul S, Chabrun F, Genebrier S, N'Guyen M, Valarche G, Derieppe A, Villoteau A, Lacombe V, Urbanski G. J Clin Med, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.